Question 1

What is Skyhawk Therapeutics?

Accepted Answer

Skyhawk Therapeutics is a Entity.

Question 2

How often does Skyhawk Therapeutics appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 15 articles.

Question 3

When was Skyhawk Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jun 30, 2026.

Question 4

When was Skyhawk Therapeutics last mentioned in news?

Accepted Answer

Last active on Jul 14, 2026.

Question 5

What is Skyhawk Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 72 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Skyhawk Therapeutics in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Skyhawk Therapeutics?

Accepted Answer

Skyhawk SKY-0515 Huntington's Trial Results (Jun 30, 2026, 7 articles).

Question 8

How did the "Skyhawk SKY-0515 Huntington's Trial Results" event impact Skyhawk Therapeutics?

Accepted Answer

Skyhawk Therapeutics announced positive 12-month interim data from its Phase 1/2 clinical trial of SKY-0515 for Huntington s disease, showing favorable trends across key metrics and reductions in disease-related proteins. This positive development significantly enhances the company's prospects and validates its SKYSTAR platform.

Question 9

How did the "Skyhawk expands FALCON-HD trial to US, UK, Canada" event impact Skyhawk Therapeutics?

Accepted Answer

Skyhawk Therapeutics is the developer of SKY-0515 and the sponsor of the FALCON-HD trial. The expansion of the trial and positive Phase 1/2 data enhance its pipeline value and potential for future revenue.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.